→   R&D   →   R&D Status

    R&D Status

    Protox is dedicated to research and development to become a company
    that produces the world’s highest quality botulinum toxin products.

    Botulinum toxin

    View Product
    Development of Botulinum toxin product ‘PROTOXIN (tentative name)’
    for Aesthetic and Therapeutic.

    Protoxin is the type of the vaccum drying injections after separation
    and refining of the nerve toxic proteins refined from the
    anaerobic bacteria ‘Clostridium botulinum type A’

    The study and development of the next-generation botulinum toxins

    Protox is now focusing on research and development for the
    product of the next generation high-purity ‘Botulinum Toxin’
    improved on formulation and function in comparison with the
    existing products.

    Indication

    Aesthetic

    • Lateral canthal lines, Frown lines
    • Restless Legs Syndrome, Trapezius muscle treatment
    • Benign Masseteric Hypertrophy

    Therapeutic

    • Essential Bleaphrospasm
    • Hemifacial spasm
    • Cervical dystonia
    • Spastic cerebral palsy
    • Post-Stroke Upper Limb Spasticity
    • Hyperhidrosis
    • Chronic migraine
    • Overactive bladder, Neurogenic detrusor overactivity